A Study to Evaluate the Efficacy and Safety of LZM012 ( Psoriasis )

NCT07746479 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
244
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Livzon Pharmaceutical Group Inc.